Your browser doesn't support javascript.
loading
Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium.
Balgobind, Brian V; Visser, Jorrit; Grehn, Melanie; Marquard Knap, Marianne; de Ruysscher, Dirk; Levis, Mario; Alcantara, Pino; Boda-Heggemann, Judit; Both, Marcus; Cozzi, Salvatore; Cvek, Jakub; Dieleman, Edith M T; Elicin, Olgun; Giaj-Levra, Niccolò; Jumeau, Raphaël; Krug, David; Algara López, Manuel; Mayinger, Michael; Mehrhof, Felix; Miszczyk, Marcin; Pérez-Calatayud, Maria José; van der Pol, Luuk H G; van der Toorn, Peter-Paul; Vitolo, Viviana; Postema, Pieter G; Pruvot, Etienne; Verhoeff, Joost C; Blanck, Oliver.
Affiliation
  • Balgobind BV; Department of Radiation Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands. Electronic address: b.v.balgobind@amsterdamumc.nl.
  • Visser J; Department of Radiation Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
  • Grehn M; Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Marquard Knap M; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • de Ruysscher D; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University, Maastricht, the Netherlands.
  • Levis M; Department of Oncology, University of Torino, Torino, Italy.
  • Alcantara P; Department of Radiation Oncology, Hospital Clínico San Carlos, Faculty of Medicine, University Complutense of Madrid, Madrid, Spain.
  • Boda-Heggemann J; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Both M; Department of Radiology and Neuroradiology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Cozzi S; Radiation Oncology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy; Radiation Oncology Department, Centre Léon Bérard, Lyon, France.
  • Cvek J; Department of Oncology, University Hospital and Faculty of Medicine, Ostrava, Czech Republic.
  • Dieleman EMT; Department of Radiation Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
  • Elicin O; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Giaj-Levra N; Department of Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
  • Jumeau R; Department of Radio-Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Krug D; Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Algara López M; Department of Radiotherapy, Hospital del Mar, Universitat Pompeu Fabra, Barcelona, Spain.
  • Mayinger M; Department of Radiation Oncology, University Hospital of Zurich, Zurich, Switzerland.
  • Mehrhof F; Department for Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Miszczyk M; IIIrd Radiotherapy and Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
  • Pérez-Calatayud MJ; Department of Radiation Oncology, Hospital General Valencia, Valencia, Spain.
  • van der Pol LHG; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands.
  • van der Toorn PP; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands.
  • Vitolo V; Radiation Oncology Clinical Department, National Center of Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
  • Postema PG; Department of Cardiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
  • Pruvot E; Heart and Vessel Department, Service of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Verhoeff JC; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Blanck O; Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
Radiother Oncol ; 189: 109949, 2023 12.
Article in En | MEDLINE | ID: mdl-37827279
ABSTRACT
BACKGROUND AND

PURPOSE:

In patients with recurrent ventricular tachycardia (VT), STereotactic Arrhythmia Radioablation (STAR) shows promising results. The STOPSTORM.eu consortium was established to investigate and harmonise STAR treatment in Europe. The primary goals of this benchmark study were to standardise contouring of organs at risk (OAR) for STAR, including detailed substructures of the heart, and accredit each participating centre. MATERIALS AND

METHODS:

Centres within the STOPSTORM.eu consortium were asked to delineate 31 OAR in three STAR cases. Delineation was reviewed by the consortium expert panel and after a dedicated workshop feedback and accreditation was provided to all participants. Further quantitative analysis was performed by calculating DICE similarity coefficients (DSC), median distance to agreement (MDA), and 95th percentile distance to agreement (HD95).

RESULTS:

Twenty centres participated in this study. Based on DSC, MDA and HD95, the delineations of well-known OAR in radiotherapy were similar, such as lungs (median DSC = 0.96, median MDA = 0.1 mm and median HD95 = 1.1 mm) and aorta (median DSC = 0.90, median MDA = 0.1 mm and median HD95 = 1.5 mm). Some centres did not include the gastro-oesophageal junction, leading to differences in stomach and oesophagus delineations. For cardiac substructures, such as chambers (median DSC = 0.83, median MDA = 0.2 mm and median HD95 = 0.5 mm), valves (median DSC = 0.16, median MDA = 4.6 mm and median HD95 = 16.0 mm), coronary arteries (median DSC = 0.4, median MDA = 0.7 mm and median HD95 = 8.3 mm) and the sinoatrial and atrioventricular nodes (median DSC = 0.29, median MDA = 4.4 mm and median HD95 = 11.4 mm), deviations between centres occurred more frequently. After the dedicated workshop all centres were accredited and contouring consensus guidelines for STAR were established.

CONCLUSION:

This STOPSTORM multi-centre critical structure contouring benchmark study showed high agreement for standard radiotherapy OAR. However, for cardiac substructures larger disagreement in contouring occurred, which may have significant impact on STAR treatment planning and dosimetry evaluation. To standardize OAR contouring, consensus guidelines for critical structure contouring in STAR were established.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Planning, Computer-Assisted / Tachycardia, Ventricular Limits: Humans Language: En Journal: Radiother Oncol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Planning, Computer-Assisted / Tachycardia, Ventricular Limits: Humans Language: En Journal: Radiother Oncol Year: 2023 Document type: Article
...